Supply of Licensed Compound Sample Clauses

Supply of Licensed Compound. Licensed Product. Licensor shall be responsible, at Licensor's expense, for supplying Schering with Licensed Compound (in the form of bulk active), from Licensor's existing inventory of Licensed Compound, to enable Schering to perform [ * ], for such Licensed Compound for the Primary Indication. In addition, Licensor has the limited option to supply all of Schering's requirements of Licensed Products as set forth in Section 3.3(b). All Licensed Compound to be supplied by Licensor hereunder shall be delivered FCA (Kenilworth, New Jersey) (Incoterms 1990) via a carrier to be specified by Schering. Licensor warrants and represents that all supplies of Licensed Compound provided to Schering by Licensor shall conform to the applicable specifications for such Licensed Compound and were prepared in accordance with current Good Manufacturing Practices ("cGMPs") and other applicable federal, national, state and local laws and regulations in effect at the time of manufacture. Schering shall be responsible for the formulation and packaging of the Licensed Compound provided by Licensor hereunder, and for manufacture and supply of all Licensed Compound and/or Licensed Product necessary for the performance of [ * ] and for supplying all commercial quantities of Licensed Compound and Licensed Products. Licensor shall transfer to Schering all Licensor Know-How relating to the manufacture of Licensed Compound, and at Schering's request and expense shall provide reasonable technical support to facilitate the implementation of such manufacturing technology at Schering.
Sample 1Sample 2Sample 3See All (6)
AutoNDA by SimpleDocs
Supply of Licensed Compound. 3.6.1 If reasonably feasible (as determined solely by AstraZeneca), AstraZeneca may sell to Licensee up to [***] of Licensed Compound (the “Inventory”) at a cost of [***]. In accordance with the Transition Plan, AstraZeneca shall deliver or have delivered the Inventory to Licensee EXW (Incoterms 2010) at a facility designated by AstraZeneca, together with a certificate of analysis certifying that the Inventory was (a) manufactured in accordance with the Specifications, all Applicable Laws and cGMP, and (b) stored by AstraZeneca prior to delivery in accordance with AstraZeneca’s standard procedures, all Applicable Laws and cGMP.
Sample 1Sample 2
Supply of Licensed Compound. Except as expressly set forth in Section 3.1 and the Supply Agreement and the Quality Agreement, as between the Parties, Insmed shall have the sole responsibility for, at its expense, Manufacturing (or having Manufactured) and supplying the Licensed Compound and Licensed Products for its Development and Commercialization activities in the Territory. *** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Sample 1
Supply of Licensed Compound. If at any time following the completion of Manufacturing Technology Transfer pursuant to Section 7.4, either Party requests the other Party to supply the requesting Party with certain quantities of the Licensed Compound for the requesting Party to Develop and Commercialize the Licensed Product in its Territory, the other Party shall reasonably consider such request in good faith, subject to any issues of Manufacturing capability and capacity and potential regulatory impact on the other Party and/or its supply network. If the other Party agrees to supply the requesting Party with the Licensed Compound in accordance with this Section 7.5, the requesting Party shall pay the other Party a supply price equal to the other Party’s Manufacturing Cost plus a reasonable mark-up to be agreed upon by the Parties.
Sample 1
Supply of Licensed Compound 
Sample 1

Related to Supply of Licensed Compound

  • Licensed Product “Licensed Product” shall mean any article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights. For clarity, a “Licensed Product” shall not include other product or material that (a) is used in combination with Licensed Product, and (b) does not constitute an article, composition, apparatus, substance, chemical material, method, process or service whose manufacture, use, or sale is covered or claimed by a Valid Claim within the Patent Rights.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Product The term “

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Licensed Technology The term "Licensed Technology" shall mean the ------------------- Licensed Patents, plus all improvements thereto developed by Licensor, and all related data, know-how and technology.

  • Supply of Product The JDC shall be responsible for determining the sources of, and arrangements for, the manufacture and supply of Products that the JDC believes will result in long-term profit maximization for such Products. The JDC shall endeavor to [ * ].

  • Manufacture (a) Manufacturer shall only manufacture the specific number of Products as requested by Company and at no time shall manufacture excess goods or overruns. Manufacturer shall not sell any Products bearing the Trademarks to any third parties without the express written consent of Company.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!